QYUNS-B(02509): The China Securities Regulatory Commission has issued a notice letter regarding the filing for the full circulation of H shares of the company.

date
21:10 21/01/2025
avatar
GMT Eight
China Resources Biotech-B (02509) announces that the company has received notification from the China Securities Regulatory Commission that the date of issuance for the application is in 2025...
QYUNS-B (02509) announced that the company has received a record notification letter from the China Securities Regulatory Commission dated January 20, 2025 for the application. According to the record notification letter, the 17.3224 million domestic shares issued by the company have been converted into H shares and listed on the Stock Exchange of Hong Kong. If the share conversion is not completed within 12 months from the date of the record notification letter, the company must update the record materials to the China Securities Regulatory Commission for further approval.